Literature DB >> 12524439

Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.

Kristina S Kovacina1, Grace Y Park, Sun Sik Bae, Andrew W Guzzetta, Erik Schaefer, Morris J Birnbaum, Richard A Roth.   

Abstract

Akt (also called protein kinase B) is one of the major downstream targets of the phosphatidylinositol 3-kinase pathway. This protein kinase has been implicated in insulin signaling, stimulation of cellular growth, and inhibition of apoptosis as well as transformation of cells. Although a number of cellular proteins have been identified as putative targets of the enzyme, additional substrates may play a role in the varied responses elicited by this enzyme. We have used a combination of 14-3-3 binding and recognition by an antibody to the phosphorylation consensus of the enzyme to identify and isolate one of the major substrates of Akt, which is also a 14-3-3 binding protein. This 40-kDa protein, designated PRAS40, is a proline-rich Akt substrate. Demonstration that it is a substrate of Akt was accomplished by showing that 1) PRAS40 was phosphorylated in vitro by purified Akt on the same site that was phosphorylated in insulin-treated cells; 2) activation of an inducible Akt was alone sufficient to stimulate the phosphorylation of PRAS40; and 3) cells lacking Akt1 and Akt2 exhibit a diminished ability to phosphorylate this protein. Thus, PRAS40 is a novel substrate of Akt, the phosphorylation of which leads to the binding of this protein to 14-3-3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524439     DOI: 10.1074/jbc.M210837200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  158 in total

Review 1.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

2.  PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.

Authors:  Matthew P Stokes; Charles L Farnsworth; Albrecht Moritz; Jeffrey C Silva; Xiaoying Jia; Kimberly A Lee; Ailan Guo; Roberto D Polakiewicz; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2012-02-09       Impact factor: 5.911

3.  PRAS40 regulates protein synthesis and cell cycle in C2C12 myoblasts.

Authors:  Abid A Kazi; Charles H Lang
Journal:  Mol Med       Date:  2010-05-05       Impact factor: 6.354

Review 4.  Metabolic benefits of resistance training and fast glycolytic skeletal muscle.

Authors:  Nathan K LeBrasseur; Kenneth Walsh; Zoltan Arany
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

5.  Calorie restriction leads to greater Akt2 activity and glucose uptake by insulin-stimulated skeletal muscle from old rats.

Authors:  Haiyan Wang; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

6.  PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.

Authors:  Xiaoxing Xiong; Rong Xie; Hongfei Zhang; Lijuan Gu; Weiying Xie; Michelle Cheng; Zhihong Jian; Kristina Kovacina; Heng Zhao
Journal:  Neurobiol Dis       Date:  2014-02-27       Impact factor: 5.996

7.  Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells.

Authors:  Lihong Wang; Cresson D Fraley; Jesika Faridi; Arthur Kornberg; Richard A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-11       Impact factor: 11.205

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  Increased Activity of the Chondrocyte Translational Apparatus Accompanies Osteoarthritic Changes in Human and Rodent Knee Cartilage.

Authors:  Olga Katsara; Mukundan Attur; Rachel Ruoff; Steven B Abramson; Victoria Kolupaeva
Journal:  Arthritis Rheumatol       Date:  2017-03       Impact factor: 10.995

10.  CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.

Authors:  Hernan Roca; Zachary S Varsos; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.